| Comprehensive analysis of genetic ancestry and its molecular correlates in cancer J Carrot-Zhang, N Chambwe, JS Damrauer, TA Knijnenburg, ... Cancer Cell 37 (5), 639-654. e6, 2020 | 180 | 2020 |
| mTOR inhibition restores amino acid balance in cells dependent on catabolism of extracellular protein M Nofal, K Zhang, S Han, JD Rabinowitz Molecular cell 67 (6), 936-946. e5, 2017 | 86 | 2017 |
| Detection of pathogenic variants with germline genetic testing using deep learning vs standard methods in patients with prostate cancer and melanoma SH AlDubayan, JR Conway, SY Camp, L Witkowski, E Kofman, ... JAMA 324 (19), 1957-1969, 2020 | 37 | 2020 |
| Germline predisposition to pediatric Ewing sarcoma is characterized by inherited pathogenic variants in DNA damage repair genes R Gillani, SY Camp, S Han, JK Jones, H Chu, S O’Brien, EL Young, ... The American Journal of Human Genetics 109 (6), 1026-1037, 2022 | 25 | 2022 |
| GCN2 adapts protein synthesis to scavenging-dependent growth M Nofal, T Wang, L Yang, CSR Jankowski, SHJ Li, S Han, L Parsons, ... Cell Systems 13 (2), 158-172. e9, 2022 | 15 | 2022 |
| Mutational footprint of platinum chemotherapy in a secondary thyroid cancer J Schiantarelli, T Pappa, J Conway, J Crowdis, B Reardon, F Dietlein, ... JCO Precision Oncology 6, e2200183, 2022 | 2 | 2022 |
| Analytical protocol to identify local ancestry-associated molecular features in cancer J Carrot-Zhang, S Han, W Zhou, JS Damrauer, A Kemal, AC Berger, ... STAR protocols 2 (4), 100766, 2021 | 2 | 2021 |
| Integrative Analysis of Germline Rare Variants in Clear and Non-Clear Cell Renal Cell Carcinoma S Han, SY Camp, H Chu, R Collins, R Gillani, J Park, Z Bakouny, ... medRxiv, 2023.01. 18.23284664, 2023 | 1 | 2023 |
| Analysis of germline-driven ancestry-associated gene expression in cancers N Chambwe, RW Sayaman, D Hu, S Huntsman, J Carrot-Zhang, ... STAR protocols 3 (3), 101586, 2022 | 1 | 2022 |
| Expanding the diagnostic yield of germline genetic testing in cancer patients using deep learning. SH Aldubayan, J Conway, L Witkowski, E Kofman, B Reardon, S Camp, ... Journal of Clinical Oncology 38 (15_suppl), 1518-1518, 2020 | 1 | 2020 |
| Characteristics of Rare Germline ATM Variants in Chronic Lymphocytic Leukemia (CLL) K Mashima, BL Lampson, A Gupta, N Moore, A Petrackova, SJ Shupe, ... Blood 140 (Supplement 1), 9853-9854, 2022 | | 2022 |
| Patients with Deleterious Germline Variants in STXBP2 Develop Toxicity after CAR-T Cell Therapy with Axicabtagene Ciloleucel MB Leick, S Han, KME Gallagher, H Silva, G Martin, S Camp, H Chu, ... Blood 140 (Supplement 1), 646-647, 2022 | | 2022 |
| Low-pass Whole Genome Imputation Enables the Characterization of Polygenic Breast Cancer Risk in the Indigenous Arab Population M Al-Jumaan, H Chu, A Al-Sulaiman, SY Camp, S Han, R Gillani, ... medRxiv, 2022 | | 2022 |
| Evaluating pathogenic germline variants in checkpoint kinase 2 (CHEK2) in ovarian germ cell tumors SY Camp, S Han, SH AlDubayan, EM Van Allen Cancer Research 80 (16_Supplement), 2125-2125, 2020 | | 2020 |
